The Wellness & Cannabis King Irwin Simon
"At Aphria, we're setting ourselves apart from the rest of the cannabis industry, generating some of the strongest sales growth, maintaining one of the strongest balance sheets and cash positions, compelling consumer brands, and well-diversified global business. Throughout the fiscal year and more recently, we further strengthened our leadership team in Leamington across core functions, for examples, in the areas of production, packaging, HR, quality, and operation. The team is doing a great job of efficiently integrating Aphria Diamond to our processes. We are consistently working to generate greater yields at lower cost. We are pleased that in Q4 cash cost per gram remained below $1 for the second straight quarter and decreased 5% from Q3 to $0.88. We are pleased with the quick ramp-up of quality product that is coming today from Aphria Diamond. We're excited about the tremendous growth opportunities in Canada, as well as our strong medical adult-use brand sales, extraction capabilities, and our ability to export EU GMP products and white label opportunities. From enhancing our global team, our brand-building activities, new facilities, and production capabilities to investing in R&D, Aphria is well-positioned for future growth."